The emerging role of EpCAM in cancer and stem cell signaling.

Initially discovered as a dominant antigen on colon carcinomas, the epithelial cell adhesion molecule (EpCAM) was considered a mere cell adhesion molecule and reliable surface-binding site for therapeutic antibodies. Recent findings can better explain the relevance of EpCAM's high-level expression on human cancers and cancer propagating cells, and its negative prognostic potential for survival of patients with certain cancers. EpCAM has oncogenic potential and is activated by release of its intracellular domain, which can signal into the cell nucleus by engagement of elements of the wnt pathway.

[1]  M. Zöller.  Tetraspanins: push and pull in suppressing and promoting metastasis , 2009, Nature Reviews Cancer.

[2]  Markus Münz,et al.  The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation , 2004, Oncogene.

[3]  R L Juliano,et al.  Signal transduction by cell adhesion receptors and the cytoskeleton: functions of integrins, cadherins, selectins, and immunoglobulin-superfamily members. , 2002, Annual review of pharmacology and toxicology.

[4]  O. Gires,et al.  On the abundance of EpCAM on cancer stem cells , 2009, Nature Reviews Cancer.

[5]  M. Brizzi,et al.  Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression. , 2009, Cancer research.

[6]  Xin Wei Wang,et al.  Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma. , 2007, Cancer research.

[7]  O. Gires,et al.  EpCAM (CD326) finding its role in cancer , 2007, British Journal of Cancer.

[8]  U. Moens,et al.  The multifunctional roles of the four-and-a-half-LIM only protein FHL2 , 2006, Cellular and Molecular Life Sciences CMLS.

[9]  H. Clevers,et al.  Wnt signalling in stem cells and cancer , 2005, Nature.

[10]  I. Nagtegaal,et al.  Loss of membranous Ep-CAM in budding colorectal carcinoma cells , 2007, Modern Pathology.

[11]  M. Harmsen,et al.  Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule. , 2007, The American journal of pathology.

[12]  M. Zöller,et al.  Claudin-7 Regulates EpCAM-Mediated Functions in Tumor Progression , 2009, Molecular Cancer Research.

[13]  T. Fleming,et al.  Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion. , 2009, Cancer research.

[14]  S. Shinton,et al.  Mice heterozygous for germ-line mutations in methylthioadenosine phosphorylase (MTAP) die prematurely of T-cell lymphoma. , 2009, Cancer research.

[15]  Y. Hannun,et al.  EpCAM Is Overexpressed in Breast Cancer and Is a Potential Target for Breast Cancer Gene Therapy , 2004, Cancer Research.

[16]  Yan Liu,et al.  Activating transcription factor 2 and c-Jun-mediated induction of FoxP3 for experimental therapy of mammary tumor in the mouse. , 2009, Cancer research.

[17]  Brigitte Mack,et al.  Nuclear signalling by tumour-associated antigen EpCAM , 2009, Nature Cell Biology.

[18]  M. Herlyn,et al.  Monoclonal antibodies in cell‐mediated cytotoxicity against human melanoma and colorectal carcinoma , 1979, European journal of immunology.

[19]  R. Young,et al.  Stem Cells, the Molecular Circuitry of Pluripotency and Nuclear Reprogramming , 2008, Cell.

[20]  J. Visvader,et al.  Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.

[21]  D. Speicher,et al.  Colorectal carcinoma invasion inhibition by CO17-1A/GA733 antigen and its murine homologue. , 1998, Journal of the National Cancer Institute.

[22]  J. Borlak,et al.  A genome-wide expression analysis identifies a network of EpCAM-induced cell cycle regulators , 2008, British Journal of Cancer.

[23]  I. B. Briaire-de Bruijn,et al.  Cadherins are regulated by Ep-CAM via phosphaditylinositol-3 kinase , 2007, Molecular and Cellular Biochemistry.